Warner Chilcott gains FDA nod for oral contraceptives

05/10/2013 | RTT News

The FDA has granted Warner Chilcott approval for its norethindrone acetate and ethinyl estradiol chewable tablets and ferrous fumarate tablets. The oral contraceptives are expected to be released in August.

View Full Article in:

RTT News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC